Prognostic value of PSMA PET against CHAARTED criteria in an ENZAMET sub-cohort.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Zahra Sabahi, Nathan Papa, Wolfgang Peter Fendler, Andrew Nguyen, Keith Wong, Narjess Ayati, Bao Ho, Jeffrey Chen, Thomas Cusick, Irene Burger, Megan Crumbaker, Gavin M. Marx, Shikha Sharma, Mark Frydenberg, Shahneen Sandhu, Ian D. Davis, Martin R. Stockler, Christopher Sweeney, Anthony M. Joshua, Louise Emmett, The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
Institutions: Garvan Institute of Medical Research, St Vincent's Hospital Sydney, Monash University, Essen University Hospital, University of Duisburg-Essen, UNSW Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, University Hospital Zurich, The Kinghorn Cancer Centre, Sydney Adventist Hospital, Cabrini Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Eastern Health, The University of Sydney, The University of Adelaide
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Cancer Council Australia
OpenAlex ID: W4410811665